A noninvasive electroceutical device that applies gene-specific bioelectric stimulation to accelerate bone regeneration in traumatic fractures and orthopedic recovery. It is the company's lead program, developed with Department of Defense support, and is being advanced toward a Breakthrough Device Designation.